Coronary Thrombolysis: Streptokinase or Recombinant Tissue-Type Plasminogen Activator?
Author:
- 1 April 1990
- journal article
- clinical trial
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 112 (7) , 529-538
Abstract
In patients with acute myocardial infarction, intravenous streptokinase therapy recanalizes 40% to 45% of occluded coronary arteries and reduces mortality by 25%. Recombinant tissue-type plasminogen activator (rt-PA) therapy is more potent for coronary arterial thrombolysis, producing both more rapid and more frequent (65% to 70%) reperfusion. Side effects (mainly reocclusion and bleeding) of streptokinase and rt-PA therapy are not markedly different. Whether the higher efficacy of rt-PA therapy will translate into a comparably larger reduction of morbidity and mortality remains to be determined in large comparative clinical trials. Both agents are available for clinical use. At present, the choice of agent for treating acute myocardial infarction must be based on consideration of the lower cost of streptokinase therapy compared with the established higher efficacy of rt-PA therapy for coronary recanalization.Keywords
This publication has 56 references indexed in Scilit:
- Immediate vs Delayed Catheterization and Angioplasty Following Thrombolytic Therapy for Acute Myocardial InfarctionJAMA, 1988
- Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction: Controlled comparison with intracoronary streptokinaseJACC, 1988
- Acute coronary thrombolysis with recombinant human tissue-type plasminogen activator: Initial patency and influence of maintained infusion on reocclusion rateThe American Journal of Cardiology, 1987
- Appraisal of various thrombolytic agents in the treatment of acute myocardial infarctionThe American Journal of Medicine, 1987
- Intravenous urokinase in acute myocardial infarctionThe American Journal of Cardiology, 1985
- Thrombolytic therapy for acute transmural myocardial infarctionThe American Journal of Medicine, 1984
- Intravenous versus intracoronary streptokinase therapy for acute myocardial infarction in community hospitalsThe American Journal of Cardiology, 1984
- Randomized comparison of intravenous versus intracoronary streptokinase for myocardial infarctionThe American Journal of Cardiology, 1984
- Thrombolysis in acute myocardial infarction: effect of intravenous followed by intracoronary streptokinase application on estimates of infarct sizeThe American Journal of Cardiology, 1984
- Coronary thrombolysis by intravenous streptokinase in acute myocardial infarction: Acute and follow-up studiesThe American Journal of Cardiology, 1984